Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience

January 2025 in “ Clinical Cosmetic and Investigational Dermatology ”

Elena Tay, Wei Jing Loo

clascoterone androgen receptor inhibitor acne vulgaris topical treatment

Studysummary This case series involving 10 patients treated with clascoterone cream 1% for acne vulgaris found it effective and well-tolerated, regardless of severity, age, gender, or ethnicity, and noted additional benefits for related skin conditions.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on dovepress.com →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research Guidelines of Care for the Management of Acne Vulgaris

5 citations , January 2024 in “Journal of the American Academy of Dermatology”

This study provided 18 evidence-based recommendations for managing acne vulgaris, strongly endorsing treatments like benzoyl peroxide, topical retinoids, and oral isotretinoin for severe cases, and issued conditional recommendations for therapies like salicylic acid and spironolactone, while offering good practice statements on combining treatment methods.

research Use of Topical Clascoterone for the Treatment of Hidradenitis Suppurativa

10 citations , April 2023 in “JAAD Case Reports”

This article discusses the challenges in treating hidradenitis suppurativa, highlighting that adalimumab is currently the only FDA-approved treatment, and reports no clinical results.

research Clascoterone as a Novel Treatment for Androgenetic Alopecia

5 citations , May 2020 in “Clinical and Experimental Dermatology”

This correspondence discusses clascoterone as a potential new treatment for androgenetic alopecia but reports no clinical results.

A Summary of In Vitro, Phase I, and Phase II Studies Evaluating the Mechanism of Action, Safety, and Efficacy of Clascoterone (Cortexolone 17a Propionate, CB-03-01) in Androgenetic Alopecia

research A Summary of In Vitro, Phase I, and Phase II Studies Evaluating the Mechanism of Action, Safety, and Efficacy of Clascoterone (Cortexolone 17a Propionate, CB-03-01) in Androgenetic Alopecia

3 citations , August 2019 in “Journal of The American Academy of Dermatology”

Clascoterone safely promotes hair growth similar to minoxidil.

research Hormonal Treatment of Acne Vulgaris: An Update

46 citations , September 2016 in “Clinical, Cosmetic and Investigational Dermatology”

This article reviews the hormonal pathogenesis and treatment strategies for acne vulgaris, particularly in women with severe or treatment-resistant cases, associating it with hormonal imbalances and hyperandrogenism.